International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) that enables a comprehensive assessment of the range of NMS in PD both for the identification of problems and for the measurement of outcome. Against this background, a multidisciplinary group of experts, including patient group representatives, has developed an NMS screening questionnaire comprising 30 items. This instrument does not provide an overall score of disability and is not a graded or rating instrument. Instead, it is a screening tool designed to draw attention to the presence of NMS and initiate further investigation. In this article, we present the results from an international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest). Data from 123 PD patients and 96 controls were analyzed. NMS were highly significantly more prevalent in PD compared to controls (PD NMS, median = 9.0, mean = 9.5 vs. control NMS, median = 5.5, mean = 4.0; Mann–Whitney, Kruskal–Wallis, and t test, P < 0.0001), with PD patients reporting at least 10 different NMS on average per patient. In PD, NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease. Furthermore, frequently, problems such as diplopia, dribbling, apathy, blues, taste and smell problems were never previously disclosed to the health professionals. © 2006 Movement Disorder Society

[1]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[2]  K Whetten-Goldstein,et al.  The Burden of Parkinson's Disease on Society, Family, and the Individual , 1997, Journal of the American Geriatrics Society.

[3]  H. Singer,et al.  Anti‐basal ganglia antibodies in PANDAS , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  M. Martens,et al.  Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[5]  J. Larsen,et al.  Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[6]  James Parkinson,et al.  An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[7]  J. Jankovic,et al.  Palatal myoclonus: An unusual presentation , 2005, Movement disorders : official journal of the Movement Disorder Society.

[8]  Mark Stacy,et al.  Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment , 2005, Movement disorders : official journal of the Movement Disorder Society.

[9]  P. James An Essay on the Shaking Palsy , 1817, The Medico-Chirurgical Journal and Review.

[10]  C. Naylor,et al.  Burden of parkinsonism: A population‐based study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[11]  C. Clarke,et al.  QUALITY OF LIFE AND CARE IN PARKINSON'S DISEASE , 1995, The British journal of clinical practice.

[12]  S. Leurgans,et al.  Addressing non-motor impairments in Parkinson's disease: The new version of the UPDRS , 2005 .

[13]  Johan Marinus,et al.  Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[14]  Fabrizio Stocchi,et al.  Factors impacting on quality of life in Parkinson's disease: Results from an international survey , 2002, Movement disorders : official journal of the Movement Disorder Society.

[15]  A. Lang Treatment of progressive supranuclear palsy and corticobasal degeneration , 2005, Movement disorders : official journal of the Movement Disorder Society.

[16]  Marjan Jahanshahi,et al.  What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[17]  D. Aarsland,et al.  Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study , 2000, Journal of the American Geriatrics Society.

[18]  J. Sergeant,et al.  Recent developments in pain in dementia , 2005, BMJ : British Medical Journal.

[19]  K. Ray Chaudhuri,et al.  The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential , 2005, Current neurology and neuroscience reports.

[20]  Jeremy Holmes,et al.  Direct economic impact of Parkinson's disease: A research survey in the United Kingdom , 2003, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Hely,et al.  Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[22]  M. Okun,et al.  Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. , 2002, Archives of neurology.

[23]  W. Weiner,et al.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.

[24]  C. Tanner,et al.  Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.